Consensus statement on the management of the GH-treated adolescent in the transition to adult care

P E Clayton; R C Cuneo; A Juul; J P Monson; S M Shalet; M Tauber; European Society of Paediatric Endocrinology

doi:10.1530/eje.1.01829

Consensus statement on the management of the GH-treated adolescent in the transition to adult care

Eur J Endocrinol. 2005 Feb;152(2):165-70. doi: 10.1530/eje.1.01829.

Authors

P E Clayton¹, R C Cuneo, A Juul, J P Monson, S M Shalet, M Tauber; European Society of Paediatric Endocrinology

Affiliation

¹ Endocrine Science Research Group, University of Manchester, Oxford Road, Manchester M13 9PT, UK. peter.clayton@man.ac.uk

PMID: 15745921
DOI: 10.1530/eje.1.01829

Abstract

The European Society for Paediatric Endocrinology held a consensus workshop in Manchester, UK in December 2003 to discuss issues relating to the care of GH-treated patients in the transition from paediatric to adult life. Clinicians experienced in the care of paediatric and adult patients on GH treatment, from a wide range of countries, as well as medical representatives from the pharmaceutical manufacturers of GH participated.

Publication types

Consensus Development Conference
Review

MeSH terms

Adolescent
Adolescent Health Services*
Adult
Continuity of Patient Care*
Growth Disorders / drug therapy*
Human Growth Hormone / therapeutic use*
Humans

Substances

Human Growth Hormone